Citation Tools
PDFPoster Presentations
Spondyloarthritis - treatment
THU0397 Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis: 3-year results from a phase 3 extension trial (MEASURE 1)
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- THU0397 Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis: 3-year results from a phase 3 extension trial (MEASURE 1)